Replies to post #6291 on Anavex Life Sciences Corp (AVXL)

[Drano]

30% success in Phase 2, and 41% success in Phase 3 for neurological diseases according to the non-subscription information in your article. We're not even out of Phase 2 yet. Therefore the chance of success is far less than 50%. My point remains valid.

[scottsmith]

The implied odds here are fantastic. Given the rest of the pipeline and the current undervaluation of the company, the floor is pretty solid as well.